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The Hedgehog (Hh) signaling pathway is a key regulator of both embryonic develop‑
ment and homeostasis of adult tissues, including thymus and blood. In the thymus, Hh 
signals for differentiation, survival and proliferation in the early stages of T cell develop‑
ment, before TCR gene rearrangement. Our recent data has shown that Hh signaling also 
modulates T cell receptor (TCR) signal strength in more mature T lineage cells. We showed 
that constitutive activation of the Hh pathway in thymocytes (by transgenic expression of 
the transcriptional activator form of Gli2) decreased TCR signal strength with profound 
consequences for the thymus—allowing self‑reactive T cells to escape deletion and 
altering T cell CD4/CD8 lineage decisions. In contrast, in the Sonic Hh deficient thymus, 
TCR signaling was increased, again influencing both TCR repertoire selection and 
CD4/8 lineage commitment. In peripheral T cells, the transcriptional changes induced 
by activation of the Hh signaling pathway lead to reduced T cell activation. Hh signaling 
also attenuated ERK phosphorylation and proliferation in mature T cells on TCR ligation. 
Modulation of TCR signal strength by Hh pathway activation has importance for immunity 
as the presence or absence of Hh in the environment in which a T cell is activated would 
shape the immune response.
INTRoduCTIoN
The	hedgehog	(Hh)	family	of	secreted	intercellular	signaling	molecules	(Sonic,	Indian	
and	Desert	Hh)	modulate	 target	 gene	 expression	 via	 the	Gli	 transcription	 factors.	Hh	
proteins	 are	 essential	 morphogens	 during	 embryogenesis	 and	 the	 homeostasis	 of	 adult	
tissues,1-4	 and	 can	 influence	 differentiation,	 cell	 cycle	 progression	 and	 survival.1,5	 In	 a	
classical	model,	a	morphogen	specifies	cell	fate	by	establishment	of	a	morphogen	gradient,	




of	solid	tissues,	 the	 immune	system	is	 ‘fluid’,	made	up	of	multiple	cell	 types	that	move	
through	the	body	and	interact,	differentiate	and	respond	in	many	different	environments.	
Despite	 this	 apparent	 difference,	Hh	 signaling	has	 also	 turned	 out	 to	 be	 an	 important	
regulator	of	the	immune	system.2,6-12
The	Gli	 transcription	 factors	 (Gli1,	Gli2	 and	Gli3)	 are	 key	 to	 the	 interpretation	 of	
the	Hh	gradient	by	the	receiving	cell.1,5	They	have	distinct	temporal	and	tissue-specific	
expression	 patterns	 and	 functions.	Gli2	 is	 necessary	 to	 initiate	 the	 first	 transcriptional	
changes	induced	by	Hh	signaling.13	Gli1	is	solely	an	activator	of	transcription,	but	Gli2	





HH sIgNALINg IN THe THymus
The	specialised	environment	of	the	thymus	supports	the	maturation	of	haematopoietic	
progenitors	 into	 functional	 T	 lymphocytes	 and	 this	 involves	 bi-directional	 signaling	
between	the	thymic	epithelium	and	developing	thymocytes.	During	T	cell	development,	
thymocytes	 pass	 through	 stages	 that	 can	 be	 defined	 by	 the	 expression	 of	 cell	 surface	


















positive	 (DP)	 thymocytes,	 which	 mature	 to	 become	 CD4	 single	
positive	 (SP)	 and	 CD8	 SP	 thymocytes.	 Signaling	 by	 a	 functional	
pre-T	 cell	 receptor	 (pre-TCR)	 is	 necessary	 for	 differentiation	 from	
DN	to	DP	cell.19	Maturation	from	DP	to	SP	cell	requires	the	expres-
sion	 of	 a	 functional,	 MHC-restricted	 abTCR	 and	 involves	 TCR	
repertoire	selection.20,21	Positive	selection	of	thymocytes	that	express	






can	be	 activated	 on	TCR	binding	 to	peptide	 antigen	presented	by	
major	 histocompatibility	 complex	 (MHC)	molecules.	CD4	T	 cells	




and	 mice.2,6,7,9-12	 Shh	 is	 expressed	 by	 thymic	 epithelial	 cells	 and	
components	 of	 the	 Hh	 signaling	 pathway	 are	 expressed	 in	 the	
lymphoid	 and	 stromal	 compartments	 of	 the	 thymus.2,6,9,11,12	 Hh	
signaling	is	involved	in	the	homeostasis	of	DN	cells,	differentiation	
from	DN1	to	DN26,7,10,11	and	the	DN	to	DP	transition.2,7,10,11





HH sIgNALINg ALTeRs TCR RepeRToIRe seLeCTIoN 
ANd Cd4:Cd8 RATIo IN deveLopINg THymoCyTes
We	 produced	 transgenic	 mice	 with	 a	 transcriptional	 activator	






tion	 of	 CD4	 SP	 cells	 in	 the	 thymus,	 and	 reduced	 the	 CD4:CD8	
ratio.	Treatment	 of	 wild	 type	 (WT)	 thymus	 explants	 with	 recom-
binant	 Shh	 protein	 (r-Shh)	 also	 decreased	 the	 CD4:CD8	 ratio,	
confirming	 that	 Hh	 can	 influence	 the	 CD4/8	 lineage	 decision.	
Conversely,	 analysis	 of	 Shh-/-	 thymi	 showed	 increased	 production	
of	CD4	SP	cells	and	the	CD4:CD8	ratio,	confirming	that	Hh	sign-
aling,	and	Shh	in	particular,	does	affect	CD4/8	lineage	commitment	
under	 physiological	 conditions	 (Fig.	 1A).	Commitment	 of	 the	DP	




have	been	proposed	 to	explain	how	 the	DP	population	commit	 to	
the	CD4	or	CD8	lineage,24	and	TCR	signal	strength	during	reper-
toire	selection	has	been	shown	to	influence	SP	lineage	commitment,	
with	 a	 stronger	 signal	 favouring	 differentiation	 to	 CD4	 SP.25-27	
The	fact	that	manipulation	of	the	Hh	signal	received	by	developing	
thymocytes	 influenced	 the	CD4/8	 lineage	decision	 therefore	 raised	
the	possibility	that	Hh	was	modulating	TCR	signal	strength,	and	in	
this	way	affecting	the	 lineage	decision.	Interestingly,	we	found	that	




proportion	of	CD4	SP	cells	 found	 in	 the	Lck-Gli2DN2	transgenic,	
and	 after	 treatment	 of	 WT	 thymi	 with	 r-Shh,	 is	 a	 result	 of	 Hh	
signaling	acting	to	reduce	TCR	signal	strength.
Figure 1. Summary of Hedgehog pathway activity in CD4/8 lineage 
commitment, TCR repertoire selection and peripheral T cell activation. 
(A) Reduced Hh signaling (i.e., in Shh‑/‑ thymus) promotes CD4 lineage 
commitment resulting in increased CD4:CD8 ratio (left). In contrast increased 
Hh signaling (i.e., in transgenic Lck‑Gli2DN2 thymocytes with constitutively 
active Hh signaling, or in thymus explants treated in vitro with r‑Shh) results 
in reduced CD4:CD8 ratio (right). (B) Hh signaling negatively influences both 
positive and negative selection. Deletion of CD8 thymocytes expressing the 
transgenic TCR recognizing the male antigen HY (in the context of MHC class I) 
is impaired in Lck‑Gli2DN2 male thymus but enhanced in Shh‑/‑ male thymus 
(left). Positive selection of Lck‑Gli2DN2 CD8 cells expressing the HY‑TCR 
is also negatively affected in the female thymus whereas positive selec‑
tion of HY‑TCR transgenic thymocytes is promoted in Shh‑/‑ female thymus. 
(C) Hedgehog signaling antagonizes in vitro T cell activation. Proliferation 
and activation of peripheral Lck‑Gli2DN2 T cells was inhibited. (D) Proposed 
model for possible role of Hh signaling and T cell activation during tissue 
repair or tumor development. Damaged tissues or tumors might produce and 
secrete Hh proteins that can signal to lymphoid cells present. We predict that 
Hh pathway signaling would limit T cell activation in response to Hh secretion 



















To	 test	 this	hypothesis,	we	used	 the	HY-TCR	transgenic	model	
that	allowed	the	study	of	positive	and	negative	selection	of	CD8	SP	
cells.29	HY-TCR	 transgenic	T	 cells	 express	 a	TCR	 that	 recognises	
a	 male	 antigen,	 restricted	 by	 a	 Class	 I	 MHC	 molecule.	 In	 male	
HY	 mice,	 negative	 selection	 is	 highly	 efficient	 with	 deletion	 of	
the	male-reactive	CD8	and	DP	population.29	When	we	added	 the	





reduced	 positive	 selection	 of	 thymocytes	 expressing	 the	 transgenic	
TCR	to	the	CD8	SP	lineage	(Fig.	1B).
To	 confirm	 the	 physiological	 significance	 of	 this	 observation	
we	 analysed	 Shh	 deficient	 HY-TCR	 mice.	 Again,	 analysis	 of	 Shh	
deficiency	showed	the	opposite	effect	to	the	Lck-Gli2DN2	transgenic,	
with	more	efficient	deletion	in	males	and	increased	positive	selection	





and	 at	 the	 corticomedullary	 junction,2,6,9	 where	 TCR	 repertoire	
selection	 takes	 place.30	 Proximity	 to	 the	 Shh	 source	would	 dictate	
the	 strength	 of	TCR	 signal	 received	 by	 a	 given	 cell,	 allowing	 the	
architecture	of	the	thymus	to	influence	the	T	cell	repertoire	by	setting	








The	 way	 in	 which	 the	 transcriptional	 changes	 induced	 by	 Hh	
pathway	activation	modulate	the	TCR	signal	during	repertoire	selec-
tion	are	unknown,	and	further	investigation	is	required.
HH sIgNALINg ATTeNuATes peRIpHeRAL T-CeLL ACTIvATIoN 
ANd pRoLIFeRATIoN
On	antigen	recognition	in	the	periphery,	naïve	T	cells	are	stimu-
lated	 to	 clonally	 expand	 and	 differentiate	 into	 effector	 cells.	 This	




signaling	 events.	 The	 TCR-CD3	 complex	 recognises	 antigen	
presented	 as	 peptide	 bound	 to	MHC	molecules	 on	 the	 surface	 of	
APC,	 and	 signals	 for	T	 cell	 activation.	 In	 addition,	 for	 full	T	 cell	
activation	a	costimulatory	signal	is	required,	transduced	by	binding	
of	CD28	on	the	T	cell	 to	CD80/CD86	on	the	APC.	These	events	




the	 MAPKinase,	 PKC,	 DAG	 Kinase,	 PI3Kinase	 and	 Calcineurin	
pathways,	 leading	 to	 the	 activation	 of	 transcription	 factors	 such	
as	 NFkB,	 NFAT	 and	 AP-1.	 These	 transcription	 factors	 bind	 to	
and	 activate	 transcription	 of	 genes	 necessary	 for	T	 cell	 activation,	
including	IL‑2.32-34	Secretion	of	IL-2,	a	potent	T	cell	growth	factor,	
and	 upregulation	 of	 IL-2	Receptor	 expression	 by	 the	T	 cell,	 allow	
autocrine	control	of	T	cell	proliferation.
The	 strength	 of	 signal	 transduced	 by	 the	 naïve	T	 cell	 on	TCR	
binding,	 as	 determined	 by	 antigen	 concentration	 and	 affinity	 and	
duration	of	 the	 interaction,	 influences	 further	T	cell	maturation	to	
specialised	effector	populations.35	The	interaction	between	the	T	cell	
and	the	APC	is	enhanced	by	adhesion	molecules	and	integrins.	These	




of	both	 the	T	 cell	 and	 the	APC.	One	possible	 influence	on	T	 cell	
activation	could	be	Hh	 secretion	at	 the	 site	of	 activation.	The	 role	
of	 Shh	 in	 peripheral	 T	 cell	 activation	 and	 function,	 however,	 is	
controversial.6,37-39	We	 therefore	used	 the	Lck-Gli2DN2	 transgenic	
model	 to	 investigate	 the	effect	of	Hh	pathway	activation	on	T	cell	
activation.
In	 these	 experiments,	 in	 vitro	 activation	of	Lck-Gli2DN2	 trans-





Hh	 signaling	 has	 long	 been	 linked	 to	 proliferation,	 with	 an	
increase	 in	 Hh	 signaling	 generally	 found	 to	 enhance	 proliferation	
(for	example	in	the	development	of	limb,	taste	buds,	neural	crest	and	
thymus).4,6,10,40-44	 Consistent	 with	Hh	 promoting	 cell	 expansion,	
the	 first	Gli	 protein	 to	be	discovered,	Gli1,	was	 initially	 identified	
as	 an	 amplified	 gene	 and	 potential	 oncogene	 in	 a	 human	 glioma	
line,45,46	 and	 aberrant Hh signaling has been implicated in many	 	 	 	 	 	 	 	
common	 malignant	 tumors	 such	 as	 small	 cell	 lung	 carcinoma,	
pancreatic,	stomach	and	prostate	cancer.47-50
By	 analysis	 of	 loss-of-function	 mutants,	T	 lineage	 studies	 have	




ambiguous	 in	other	 systems,	 in	particular	 in	 the	 retina.51	 In	 chick	
and	mouse	 retina	Shh	activation	 resulted	 in	 increased	BrdU	 incor-
poration	 suggesting	 that	Hh	 signaling	 promotes	 proliferation.52-54	
However,	Hh	mutant	Zebrafish	 exhibited	prolonged	 retinal	 prolif-
eration	due	to	the	inability	of	precursor	cells	to	exit	the	cell	cycle.55	
Recent	 work	 has	 suggested	 that	 Hh	 signaling	 may	 effect	 stem,	






difference	 in	 outcome	 could	 reflect	 differences	 in	 the	 intracellular	
context	 in	which	 the	Hh	 signal	 is	 transduced,	 leading	 to	 the	 tran-




























eRK pHospHoRyLATIoN ANd HH sIgNALINg
To	 dissect	 further	 the	 effect	 of	 Hh	 signaling	 on	 TCR	 signal	
strength,	peripheral	T	cell	activation	and	proliferation,	we	followed	
the	 kinetics	 of	MAPkinase	 pathway	 activation	 by	measuring	 ERK	
phosphorylation	 after	 TCR-induced	 activation	 by	Western	 blot.57	
Presence	 of	 the	 Lck-Gli2DN2	 transgene	 led	 to	 much	 delayed	 and	
reduced	levels	of	ERK	phosphorylation,	which	was	further	confirmed	
to	be	T-cell	specific	using	a	FACS-based	assay.12
This	 reduced	 ERK	 phosphorylation	 observed	 in	 our	 transgenic	
T	cells	is	of	particular	interest,	as	previous	accounts	of	Hh	pathway	
involvement	 in	 other	 tissues	 are	 often	 linked	 to	 improved	 ERK	
phosphorylation.58-61	 For	 example,	 addition	 of	 Shh	 during	 retinal	
regeneration,	 led	 to	an	 increase	 in	ERK	phosphorylation	 indirectly	






ERK	 activity	 must	 be	 sustained	 late	 into	 G1	 to	 enable	 successful	
S-phase	 entry63	 and	 inhibitors	 of	ERK	phosphorylation	have	been	
shown	 to	 inhibit	 the	 proliferation	 of	many	 cell	 types	 including	T	
cells.57	 A	 reduction	 in	 ERK	 phosphorylation	 leads	 to	 a	 decrease	





suggesting	 that	 a	 reduction	 in	 IL‑2	 gene	 transcription	 (caused	 by	
attenuated	MAPkinase	activity64)	is	responsible	for	the	proliferative	
defect.	The	fact	the	Lck-Gli2DN2	T	cells	can	proliferate	in	response	







ImpLICATIoNs FoR ImmuNITy ANd dIseAse
Modulation	of	TCR	signal	 strength	by	Hh	has	profound	 impli-








Hh	proteins are expressed in skin, gut and lung.	 	 	 	 	 	 	 1	These	 tissues	
are	 subject	 to	 recurrent	 immune	 challenge,	 as	 they	 are	 the	 sites	 of	
entry	of	 external	 pathogens	 from	 the	 environment,	 from	 food	 and	
air.	They	are	also	subject	to	inflammatory	and	autoimmune	diseases.	
Hh	 expression	 in	 these	 tissues	during	 renewal	 or	 remodelling	 after	
infection	 or	 tissue-damage	 could	 function	 to	 dampen	 down	 the	
immune	response,	protecting	against	the	induction	of	inflammatory	
or	autoimmune	diseases	(Fig.	1D).	By	reducing	lymphocyte	responses	








TCR	 signal	 threshold	 for	mature	T	 cell	 activation.	 In	 the	 thymus,	
mutations	 increasing	 either	 Shh	 secretion	 by	 epithelial	 cells,	 or	
signal	 interpretation	by	thymocytes,	would	allow	those	self-reactive	
clones	 that	would	 normally	 be	 deleted,	 to	mature	 and	 escape	 into	
the	peripheral	lymphoid	organs,	potentially	leading	to	autoimmune	
disease.	 In	 contrast,	 mutations	 leading	 to	 decreased	 Hh	 signal	 in	
peripheral	 T	 cells	 (via	 decreased	 secretion	 in	 the	 environment	 or	
signal	 interpretation	by	 the	T	cell)	would	 increase	 the	TCR	signal,	
potentially	leading	to	inappropriate	T	cell	activation.
The	role	of	Hh	signaling	in	T	cells	(and	immunity)	is	a	new	field,	
so	 there	 is	 still	much	work	 to	be	done	 to	dissect	 its	 functions	 and	
gain	insight	into	the	molecular	mechanisms.	It	will	be	important	to	
understand	how	Hh	modulates	 the	TCR	 signal,	 and	 to	 investigate	
the	 effect	 of	Hh	 gradient	 on	 the	 signal.	 It	 will	 also	 be	 interesting	
to	 test	 if	Hh	 signaling	 regulates	 other	 components	of	 the	 immune	
system.
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